Blueprint Medicines Corp at JPMorgan Healthcare Conference Transcript
Good morning, everyone, and welcome to the J.P. Morgan Healthcare Conference. It is my pleasure to introduce you today to the Blueprint Medicines team. We have Kate Haviland, who is the CEO who will be leading the presentation today. Christy Rossi, who is COO, and Fouad Noumani, who is President, R&D, will be joining Kate during the Q&A. Post the presentation, we will set up some time for Q&A.
With that, I will hand it over to Kate. Kate, thank you so much for joining us here today, and we look forward to the presentation.
Thank you very much, [Malika]. So good morning, everyone, and thank you very much to [Phil Ross] and the entire J.P. Morgan team for inviting us here to present this year. I want to welcome, everyone in the room. It's nice to see so many people here in person and all of those who are joining us online to the webcast.
As [Malika] said, my name is Kate Haviland. I actually joined Blueprint Medicines eight years ago
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |